Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)
Sponsor: Hyundai Bioscience Co., Ltd.
Summary
This is a randomized, double-blind, placebo-controlled Phase 2/3 study to evaluate the efficacy, safety, and antiviral activity of CP-COV03 in adult patients with dengue infection.
Official title: A Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate Safety and Efficacy of CP-COV03 in Dengue Patients (Part 1) / Dengue and Dengue-like Illness Patients (Part 2)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
210
Start Date
2026-04-09
Completion Date
2027-05
Last Updated
2026-07-10
Healthy Volunteers
No
Conditions
Interventions
CP-COV03
Oral administration
Placebo
Oral administration
Locations (2)
The National Hospital of Tropical Diseases (NHTD)
Hanoi, Vietnam
Tien Giang Provincial General Hospital
Mỹ Tho, Vietnam